Handgrip strength and blood flow in liver cirrhosis
Part of Digestive system clinical trials.
This study measures how handgrip strength relates to blood flow in the portal vein (the main vein to the liver) in people with liver cirrhosis. It aims to find simple ways to check liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with liver cirrhosis.
- You have had an endoscopy to check for enlarged veins in your esophagus or stomach.
- You have not had bleeding from those veins in the last 14 days (if you are in the pressure measurement group).
- You are able to hold a handgrip device and have not had hand or wrist surgery in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a technique to measure blood pressure changes in people with cirrhosis (scarring of the liver). It may help doctors better understand liver circulation problems and guide safer treatment decisions.
This trial compares a newer, less invasive method (using an endoscope) to measure pressure in the liver's blood vessels with the standard technique. It may help people with liver disease or suspected cirrhosis better understand their condition.
This trial uses a simple ultrasound test (measuring liver and spleen stiffness) to predict if a patient with cirrhosis and advanced liver cancer has enlarged veins in the esophagus. The goal is to avoid unnecessary invasive procedures like endoscopy.
This trial looks at people with clinically significant portal hypertension, which is high blood pressure in the liver's blood vessels. It may help find better ways to manage this condition.
This trial is for people with liver cirrhosis who have high blood pressure in the vein that carries blood to the liver (portal hypertension). It uses a special ultrasound with contrast to learn more about the condition.
This study tracks people with liver cirrhosis to see how often portal vein thrombosis (a blood clot in the main vein to the liver) occurs and how it can be treated with blood thinners. It aims to improve care for those at risk of these clots.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.